Abstract
For some diseases, a line of causality exists in which a given antecedent elicits a particular disorder, which can be treated by interrupting a specific pathway of events. Most biomedical scientists have uncritically adopted the “line-of-causality” metaphor, and have therefore selected for study animal models of disease in which this metaphor by design must work because the models are chosen accordingly. Although peer review rewards the use of such models, and research with linear models of disease is often intellectually satisfying, it is doubtful that such an approach in the end will lead to breakthroughs for the treatment of the major diseases facing humankind today, such as cancer and cardiovascular disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reaven, G. M. (1988) Role of insulin resistance in human disease. Diabetes 37, 1595–1607.
Rocchini, A. P. (1995) Insulin resistance, obesity and hypertension. Am. J. Nutr. 125, 1718S–1724S.
Vega, G. L. (2001) Obesity, the metabolic syndrome, and cardiovascular disease. Am. Heart J. 142, 1108–1116.
Isomaa, B., Almgren, P., Tuomi, T., Forsen, B., Lahti, K., Nissen, M., et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689.
Marks, J. B. and Raskin, P. (1988) Nephropathy and hypertension in diabetes. Med. Clin. N Am. 82, 877–907.
Sowers, J. R. and Epstein, M. (1995) Diabetes mellitus and associated hypertension, vascular disease and nephropathy. An update. Hypertension 26, 869–879.
Zucker, L. M. and Zucker, T. F. (1961) Fatty, a new mutation in the rats. J. Hered. 52, 275–287.
Chua, S. C., Jr., White, D. W., Wu-Peng, X. S., Liu, S. M., Okada, N., Kershaw, E. E., et al. (1996) Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 45, 1141–1143.
White, D. W., Wang, Y., Chua, S. C., Jr., Morgenstern, J. P., Leibel, R. L., Baumann, H., et al. (1997) Constitutive and impaired signaling of leptin receptors containing the Gln → Pro extracellular domain fatty mutation. Proc. Natl. Acad. Sci. USA 94, 10657–10662.
Clark, J. B., Palmer, C. J., and Shaw, W. N. (1983) The diabetic Zucker fatty rat. Proc. Soc. Exp. Biol. Med. 173, 68–75.
Peterson, R. G., Shaw, W. N., Neel, M.-A., Little, L. A., and Eichberg, J. (1990) Zucker diabetic fatty rats as a model for non-insulin-dependent diabetes mellitus. ILAR News 32, 16–19.
Peterson, R. G. (2000) The Zucker diabetic fatty (ZDF) rat, in Animal Models of Diabetes: A Primer (Sima, A. A. F. and Shafrir, E., eds.), Taylor and Francis, London, UK, pp. 109–128.
Okamoto, K. and Aoki, K. (1963) Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27, 282–293.
Pinto, Y. M., Paul, M., and Ganten, D. (1998) Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovas. Res. 39, 77–88.
Yamori, Y., Tomimoto, K., Ooshima, A., Hazama, F., and Okamoto, K. (1974) Proceedings: developmental course of hypertension in the SHR-substrains susceptible to hypertensive cerebrovascular lesions. Jpn. Heart J. 15, 209–210.
Koletsky, S. (1972) New type of spontaneously hypertensive rats with hyperlipemia and endocrine gland defects, in Spontaneous Hypertension: Its Pathogenesis and Complications (Okamoto, K., ed.), Igaku Shoin Ltd., Tokyo, Japan, pp. 194–197.
Takaya, K., Ogawa, Y., Hiraoka, J., Hosoda, K., Yamori, Y., Nakao, K., et al. (1996) Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat. Genet. 14, 130–131.
Koletsky, R. J., Friedman, J. E., and Ernsberger, P. (2000) The obese spontaneously hypertensive rats (SHROB, Koletsky rats): A model of metabolic syndrome X, in Animal Models of Diabetes: A Primer (Sima, A. A. F. and Shafrir, E., eds.), Taylor and Francis, London, UK, pp. 109–128.
McCune, S. A., Baker, P. B., and Stills, H. F. Jr. (1990) SHHF/Mcc-cp rat: model of obesity, non-insulin-dependent diabetes, and congestive heart failure. ILAR News 32, 23–27.
Tofovic, S. P., Kusaka, H., Kost, C. K. Jr., and Bastacky, S. (2000) Renal function and structure in diabetic, hypertensive, obese, ZDFx SHHF-hybrid rats. Renal Fail. 22, 387–406.
Yusuf, S., Sleight, P., Pogre, J., Bosch, J., Davies, R., and Dagenais, G. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med. 342, 145–153.
Tofovic, S. P., Kusaka, H., Jackson, E. K., and Bastacky, S. I. (1999) Renal function and structure in obese ZDFxSHHF (hybrid)fa/facp rats treated with caffeine or enalapril. J. Am. Soc. Nephrol. 10, 672A.
Kost, K. C., Jr., Bastacky, S. I., Jackson, E. K., and Tofovic, S. P. (2001) Renoprotective effects of angiotensin converting enzyme inhibition in an animal model of renal disease characterized by multiple risk factors. J. Am. Soc. Nephrol. 12, 839A.
Dubey, R. K. and Jackson, E. K. (2001) Cardiovascular protective effects of 17β-estradiol metabolites. J. Appl. Physiol. 91, 1868–1883.
Tofovic, S. P., Dubey, R. K., and Jackson, E. K. (2001) 2-Hydroxyestradiol attenuates the development of obesity, metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats. J. Pharmacol. Exp. Therap. 299, 973–977.
Planche, E., Joliff, M., de Gasquet P., and Leliepvre X. (1983) Evidence of a defect in energy expenditure in 7-day-old Zucker rat (fa/fa). Am. J. Physiol. 245, E107–E113.
Meister, B. (2000) Control of food intake via leptin receptors in the hypothalamus. Vitam. Horm. 59, 265–304.
Dulloo, A. G. and Miller, D. S. (1987) Reversal of obesity in the genetically obese fa/fa Zucker rat with ephedrine/methylxanthines thermogenic mixture. J. Nutr. 117, 383–389.
Tofovic, S. P., Kost, C. Jr., Jackson, E. K., and Bastacky, S. I. (2002) Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa/fa cp) rats. Kidney Int. 61, 1433–1444.
Tofovic, S. P., Kusaka, H., Jackson E. K., and Bastacky, S. I. (2001) Renal and metabolic effects of caffeine in obese (fa/fa cp), diabetic, hypertensive, ZSF1 rats. Renal Failure 23, 159–173.
Vora, J. P., Zimsen, S. M., Houghton, D. C., and Anderson, S. (1996) Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes. J. Am. Soc. Nephrol. 7, 113–117.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Tofovic, S.P., Jackson, E.K. (2003). Rat Models of the Metabolic Syndrome. In: Goligorsky, M.S. (eds) Renal Disease. Methods in Molecular Medicine™, vol 86. Humana Press. https://doi.org/10.1385/1-59259-392-5:29
Download citation
DOI: https://doi.org/10.1385/1-59259-392-5:29
Publisher Name: Humana Press
Print ISBN: 978-1-58829-134-9
Online ISBN: 978-1-59259-392-7
eBook Packages: Springer Protocols